These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 26060278)
21. Identification of a penicillin-binding protein 3 homolog, PBP3x, in Pseudomonas aeruginosa: gene cloning and growth phase-dependent expression. Liao X; Hancock RE J Bacteriol; 1997 Mar; 179(5):1490-6. PubMed ID: 9045804 [TBL] [Abstract][Full Text] [Related]
22. Post-translational modification by β-lysylation is required for activity of Escherichia coli elongation factor P (EF-P). Park JH; Johansson HE; Aoki H; Huang BX; Kim HY; Ganoza MC; Park MH J Biol Chem; 2012 Jan; 287(4):2579-90. PubMed ID: 22128152 [TBL] [Abstract][Full Text] [Related]
23. Cloning and functional characterization of the Pseudomonas aeruginosa rhlC gene that encodes rhamnosyltransferase 2, an enzyme responsible for di-rhamnolipid biosynthesis. Rahim R; Ochsner UA; Olvera C; Graninger M; Messner P; Lam JS; Soberón-Chávez G Mol Microbiol; 2001 May; 40(3):708-18. PubMed ID: 11359576 [TBL] [Abstract][Full Text] [Related]
24. Biosynthesis of the core part of the lipopolysaccharide of Pseudomonas aeruginosa. Asonganyi TM; Meadow PM J Gen Microbiol; 1980 Mar; 117(1):1-7. PubMed ID: 6771364 [TBL] [Abstract][Full Text] [Related]
25. Loss of elongation factor P disrupts bacterial outer membrane integrity. Zou SB; Hersch SJ; Roy H; Wiggers JB; Leung AS; Buranyi S; Xie JL; Dare K; Ibba M; Navarre WW J Bacteriol; 2012 Jan; 194(2):413-25. PubMed ID: 22081389 [TBL] [Abstract][Full Text] [Related]
26. Truncation in the core oligosaccharide of lipopolysaccharide affects flagella-mediated motility in Pseudomonas aeruginosa PAO1 via modulation of cell surface attachment. Lindhout T; Lau PCY; Brewer D; Lam JS Microbiology (Reading); 2009 Oct; 155(Pt 10):3449-3460. PubMed ID: 19589832 [TBL] [Abstract][Full Text] [Related]
27. Alterations of Metabolic and Lipid Profiles in Polymyxin-Resistant Pseudomonas aeruginosa. Han ML; Zhu Y; Creek DJ; Lin YW; Anderson D; Shen HH; Tsuji B; Gutu AD; Moskowitz SM; Velkov T; Li J Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632014 [TBL] [Abstract][Full Text] [Related]
28. Elongation factor P mediates a novel post-transcriptional regulatory pathway critical for bacterial virulence. Zou SB; Roy H; Ibba M; Navarre WW Virulence; 2011; 2(2):147-51. PubMed ID: 21317554 [TBL] [Abstract][Full Text] [Related]
29. Identification of the gene encoding the mitochondrial elongation factor G in mammals. Barker C; Makris A; Patriotis C; Bear SE; Tsichlis PN Nucleic Acids Res; 1993 Jun; 21(11):2641-7. PubMed ID: 8332461 [TBL] [Abstract][Full Text] [Related]
33. YfmR is a translation factor that prevents ribosome stalling and cell death in the absence of EF-P. Hong HR; Prince CR; Tetreault DD; Wu L; Feaga HA Proc Natl Acad Sci U S A; 2024 Feb; 121(8):e2314437121. PubMed ID: 38349882 [TBL] [Abstract][Full Text] [Related]
34. Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from Intensive Care Units in The Netherlands, 1998-2005. Oudhuis GJ; Verbon A; Hoogkamp-Korstanje JA; Stobberingh EE; Int J Antimicrob Agents; 2008 Jan; 31(1):58-63. PubMed ID: 17961989 [TBL] [Abstract][Full Text] [Related]
35. Synthesis of rhamnosylated arginine glycopeptides and determination of the glycosidic linkage in bacterial elongation factor P. Wang S; Corcilius L; Sharp PP; Rajkovic A; Ibba M; Parker BL; Payne RJ Chem Sci; 2017 Mar; 8(3):2296-2302. PubMed ID: 28451332 [TBL] [Abstract][Full Text] [Related]
36. A regiospecific rhamnosyltransferase from Epimedium pseudowushanense catalyzes the 3-O-rhamnosylation of prenylflavonols. Feng K; Chen R; Xie K; Chen D; Guo B; Liu X; Liu J; Zhang M; Dai J Org Biomol Chem; 2018 Jan; 16(3):452-458. PubMed ID: 29265155 [TBL] [Abstract][Full Text] [Related]
37. Arginine Is a Critical Substrate for the Pathogenesis of Everett J; Turner K; Cai Q; Gordon V; Whiteley M; Rumbaugh K mBio; 2017 Mar; 8(2):. PubMed ID: 28292986 [TBL] [Abstract][Full Text] [Related]
38. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria. Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989 [TBL] [Abstract][Full Text] [Related]
39. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study. Millar BC; Rendall JC; Downey DG; Moore JE J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786 [TBL] [Abstract][Full Text] [Related]
40. Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli. Bergen PJ; Bulitta JB; Sime FB; Lipman J; McGregor MJ; Millen N; Paterson DL; Kirkpatrick CMJ; Roberts JA; Landersdorfer CB Diagn Microbiol Infect Dis; 2018 May; 91(1):69-76. PubMed ID: 29395712 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]